Libivirumab: Difference between revisions

Jump to navigation Jump to search
No edit summary
 
WikiBot (talk | contribs)
m Protected "Libivirumab": Protecting pages from unwanted edits ([edit=sysop] (indefinite) [move=sysop] (indefinite))
(No difference)

Revision as of 20:21, 27 September 2011

Template:Drugbox-mab

WikiDoc Resources for Libivirumab

Articles

Most recent articles on Libivirumab

Most cited articles on Libivirumab

Review articles on Libivirumab

Articles on Libivirumab in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Libivirumab

Images of Libivirumab

Photos of Libivirumab

Podcasts & MP3s on Libivirumab

Videos on Libivirumab

Evidence Based Medicine

Cochrane Collaboration on Libivirumab

Bandolier on Libivirumab

TRIP on Libivirumab

Clinical Trials

Ongoing Trials on Libivirumab at Clinical Trials.gov

Trial results on Libivirumab

Clinical Trials on Libivirumab at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Libivirumab

NICE Guidance on Libivirumab

NHS PRODIGY Guidance

FDA on Libivirumab

CDC on Libivirumab

Books

Books on Libivirumab

News

Libivirumab in the news

Be alerted to news on Libivirumab

News trends on Libivirumab

Commentary

Blogs on Libivirumab

Definitions

Definitions of Libivirumab

Patient Resources / Community

Patient resources on Libivirumab

Discussion groups on Libivirumab

Patient Handouts on Libivirumab

Directions to Hospitals Treating Libivirumab

Risk calculators and risk factors for Libivirumab

Healthcare Provider Resources

Symptoms of Libivirumab

Causes & Risk Factors for Libivirumab

Diagnostic studies for Libivirumab

Treatment of Libivirumab

Continuing Medical Education (CME)

CME Programs on Libivirumab

International

Libivirumab en Espanol

Libivirumab en Francais

Business

Libivirumab in the Marketplace

Patents on Libivirumab

Experimental / Informatics

List of terms related to Libivirumab

Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [1] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

Libivirumab is a human monoclonal antibody which is used in the treatment of viral infections.

Template:Humanmonoclonals

Template:WikiDoc Sources